COMP <GO>
OPCH vs LLY // OPERATING MARGIN
Option Care Health Inc. (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: OPCH 5
— LLY 10
▲ OPERATING MARGIN LEADER: LLY
LAST: $31.83 (-0.06%) • MKT CAP: $4.77B
operating-margins
6.00%
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
operating-margins
40.21%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OPCH VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OPCH | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 19.30% | 83.64% | -64.34 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.90% | 32.36% | -20.46 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.3x | 36.4x | -21.12 | OPCH | /valuation <GO> |
| Free Cash Flow Yield | 4.55% | 2.30% | +2.25 | OPCH | /fcf-yield <GO> |
| Operating Margin ACTIVE | 6.00% | 40.21% | -34.21 | LLY | /operating-margins <GO> |
| Net Profit Margin | 3.70% | 31.90% | -28.20 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 13.00% | 45.51% | -32.51 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.81 | 9.29 | -5.48 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.77% | +0.43 | LLY | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 84.3 | 77.9 | +6.38 | OPCH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.10 | 0.51 | +0.59 | OPCH | /macro-sensitivity <GO> |
| Forward P/E Multiple | 19.3x | 26.3x | -6.95 | OPCH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.77B | $1.33T | -$1.33T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OPCH REV | LLY REV | OPCH GROSS % | LLY GROSS % | OPCH FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.65B | $65.18B | 19.3% | 83.0% | $217.1M | $16.81B |
| FY 2024 | $5.00B | $45.04B | 20.3% | 81.3% | $287.8M | $8.82B |
| FY 2023 | $4.30B | $34.12B | 44.0% | 79.3% | $177.7M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OPCH // BETA 1.10
LLY // BETA 0.51